← Leaderboards
Connie M Arthur
Emory University
$3,739,815
Attributed
$3,739,815
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,739,815 · 3
By mechanism
R01$2,119,328 · 1
P01$1,620,487 · 2
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- James C. Zimring$24,599,687
- Sean R Stowell$18,165,764
- Allan D. Kirk$41,350,860
- Jeanne E Hendrickson$9,770,113
- Mandy L. Ford$29,844,446
Others in their field
Other Emerging Leaders on “Immunologics”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Kevin Urdahl · Seattle Children'S Hospital$85,664,942
- Yunda Huang · Fred Hutchinson Cancer Center$71,262,090
- Ted Ross · University Of Georgia$68,763,143
- Sarah Fortune · Harvard School Of Public Health$51,119,645
Research focus
ImmunologicsImmunologic FactorsAntibody FormationTransfusionInsightAntigensMediatingImmuneErythrocytesErythrocyte TransfusionB-LymphocytesSeriesMedicinePre-Clinical ModelPreventEnhancing FactorAlloantigenDendritic CellsChronicImprintAdoptive TransferCd4 Positive T LymphocytesAntigen TargetingImmune System
Grant awards (9)
Core B - Microbial glycan microarray core$419,110
P01 · FY2025 · HL · contact PI
Project 2 - Convergence of innate immunity and microbial communities in the regulation of anti-blood group antibody development$419,109
P01 · FY2025 · HL · contact PI
Project 2 - Convergence of innate immunity and microbial communities in the regulation of anti-blood group antibody development$436,124
P01 · FY2024 · HL · contact PI
Examining the Mechanisms of RBC Alloimmunization Hyperresponders$432,332
R01 · FY2024 · HL · contact PI
Core B - Microbial glycan microarray core$346,144
P01 · FY2024 · HL · contact PI
Examining the Mechanisms of RBC Alloimmunization Hyperresponders$432,332
R01 · FY2023 · HL · contact PI
Examining the Mechanisms of RBC Alloimmunization Hyperresponders$432,332
R01 · FY2022 · HL · contact PI
Examining the Mechanisms of RBC Alloimmunization Hyperresponders$432,332
R01 · FY2021 · HL · contact PI
Examining the Mechanisms of RBC Alloimmunization Hyperresponders$390,000
R01 · FY2020 · HL · contact PI